Market Cap 5.35B
Revenue (ttm) 3.21B
Net Income (ttm) 330.31M
EPS (ttm) N/A
PE Ratio 18.55
Forward PE N/A
Profit Margin 10.28%
Debt to Equity Ratio 0.17
Volume 208
Avg Vol 8,848
Day's Range N/A - N/A
Shares Out 469.71M
Stochastic %K 64%
Beta 0.51
Analysts Buy
Price Target N/A

Company Profile

Ono Pharmaceutical Co., Ltd. engages in production, purchase, and sale of pharmaceuticals and diagnostic reagents worldwide. It offers Opdivo Intravenous Infusion and Kyprolis Intravenous Injection for malignant tumors; Emend capsules intravenous injections for chemotherapy-induced nausea and vomiting; Demser capsules for the symptoms in patients with pheochromocytoma; Mektovi, Velexbru, and Braftovi capsules for malignant tumors; and ADLUMIZ tablets for cancer cachexia. It also provides Glactiv...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 81 6 6263 5670
Address:
8-2, Kyutaromachi 1-chome, Chuo-ku, Osaka, Japan
Latest News on OPHLF
No data available.